Cited by 178Fungal Infections and StudiesAntifungal resistance and susceptibilityImmune responses and vaccinations

Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum

Open access
Nosanchuk, Joshua D., Steenbergen, Judith N., Shi, Li, Deepe, George S., Casadevall, Arturo·2003·Journal of Clinical Investigation

Abstract

A protective role for antibodies has not previously been described for host defense against the pathogenic fungus Histoplasma capsulatum (Hc). Mouse mAb's were generated from mice immunized with Hc yeast that binds the cell surface of Hc. Administration of mAb's before Hc infection reduced fungal burden, decreased pulmonary inflammation, and prolonged survival in a murine infection model. Protection mediated by mAb's was associated with enhanced levels of IL-4, IL-6, and IFN-gamma in the lungs of infected mice. The mAb's increased phagocytosis of yeast by J774.16 cells through a CR3-dependent process. Ingestion of mAb-opsonized Hc by J774.16 macrophage-like cells was associated with yeast cell growth inhibition and killing. The mAb's bound to a 17-kDa antigen expressed on the surface of Hc. The antigen was identified as a histone H2B-like protein. This study establishes that mAb's to a cell surface protein of Hc alter the intracellular fate of the fungus and mediate protection in a murine model of lethal histoplasmosis, and it suggests a new candidate antigen for vaccine development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci19361

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • It is possible to generate protective mAbs against many viruses and microorganisms.

    “there is ample evidence that it is possible to generate protective mAbs against many viruses and microorganisms (Teitelbaum et al, 1998; Nosanchuk et al, 2003; Both et al, 2013).”

    From mRNA mediates passive vaccination against infectious agents, toxins, and tumors (2017) · cites this paper as Nosanchuk et al, 2003

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 64 · Cited by 178

Authors
Nosanchuk, J. D., Steenbergen, J. N., Shi, L., Deepe, G. S., & Casadevall, A.
Affiliations
  • Albert Einstein College of Medicine (US)
  • Yeshiva University (US)
  • University of Cincinnati (US)
Corresponding author
Shi, Li
Venue
Journal of Clinical Investigation
Published
2003-10-15
Volume
112
Issue
8
Pages
1164-1175
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1965606695
Cited by
178
References
64
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 11 · 2019: 8 · 2018: 8 · 2017: 13 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 7 · 2012: 11
FWCI
4.93
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • National Institutes of Health (5r01hl059842-23, 5r01ai052733-16, CA13330)
  • Center for AIDS Research, University of Washington
  • National Heart, Lung, and Blood Institute (HL 59842, R01-HL059842)
  • National Cancer Institute (CA‐13330, P30CA013330)
  • National Institute of General Medical Sciences (T32-GM-07491, T32GM007491)
  • National Institute of Allergy and Infectious Diseases (AI52733, AI-34361, AI13342, R37AI042747, R01-AI052733, R01AI034361, AI42747, AI33774, R01AI033774)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK20541, P60DK020541, P30DK020541)
Topics
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
Histoplasma capsulatum, histoplasmosis, monoclonal antibodies, antibody-mediated protection, opsonization, CR3, phagocytosis, macrophages, cytokines, vaccine candidate antigens, fungal infection
MeSH terms
Amino Acid Sequence, Animals, Antibodies, Fungal, Antibodies, Monoclonal, Antigens, Fungal, Base Sequence, Female, Fungal Proteins, Histones, Histoplasma, Histoplasmosis, Immunization, Passive, Interferon-gamma, Macrophages, Mice, Inbred BALB C, Mice, Inbred C57BL, Molecular Sequence Data, Phagocytosis, Interleukin-4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review